Dermata Therapeutics, Inc.
3525 Del Mar Heights Rd., #322
San Diego, CA 92130
May 11, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Dermata Therapeutics, Inc. |
Registration Statement on Form S-1
Filed May 4, 2022
File No. 333-264668
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Dermata Therapeutics, Inc. hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 4:00 p.m., Eastern Time, on May 13, 2022, or as soon as practicable thereafter.
Please call Steven Skolnick of Lowenstein Sandler LLP at 646-414-6947 to confirm the effectiveness of the Registration Statement or with any questions.
Very truly yours, | ||
DERMATA THERAPEUTICS, INC. | ||
By: | /s/ Gerry Proehl | |
Name: | Gerry Proehl | |
Title: | Chief Executive Officer | |